AcuCort CEO Jönmark outlines rights issue in live interview on US expansion
Bitget2026/10/06 07:01AcuCort CEO Jonas Jönmark held a live interview on Oct. 6 focused on the company’s rights issue financing. Discussion covered use of proceeds, preparations for a planned US NDA for Zeqmelit, US launch planning. Management also addressed the FDA process, international expansion strategy, and near-term corporate milestones. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief via Cision (Ref. ID: 202610060300BITN____UKPR__EN_20261005-BIT-9317-0) on October 06, 2026, and is solely responsible for the information contained therein.
- AcuCort CEO Jonas Jönmark held a live interview on Oct. 6 focused on the company’s rights issue financing.
- Discussion covered use of proceeds, preparations for a planned US NDA for Zeqmelit, US launch planning.
- Management also addressed the FDA process, international expansion strategy, and near-term corporate milestones.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cathie Wood’s ARK Sells Bitcoin ETF, SpaceX and Robinhood Shares in Portfolio Shift
Analyst Gu Jingci: 10.10 Bitcoin/Ethereum Evening Trading Strategies and Market Analysis
Tekedia Capital flags signs global bond sell-off is losing momentum
Dogecoin ETF to Shut as Bitwise CEO Flags Weak Demand